Vivek Shetty, D.D.S., Dr.Med.Dent.
(310) 825-0834
(310) 825-5170
UCLA School of Dentistry
10833 Le Conte Ave.
Box 951668
Los Angeles, CA 90095-1668
Office:  23-009 CHS


Dr. Vivek Shetty is a Professor in the Section of Oral and Maxillofacial Surgery in the Division of Diagnostic & Surgical Sciences as well as a Professor in the Department of Biomedical Engineering in the UCLA Samueli School of Engineering.

Educational & Professional Background

  • D.D.S., University of Bombay, India, 1981

  • Certificate, Universität Regensburg, Germany, (Oral/Maxillofacial Surgery), 1988

  • Fellowship, Massachusetts General Hospital, Boston (Oral/Maxillofacial Surgery), 1989

  • Fellowship, University of California, Los Angeles (Oral/Maxillofacial Surgery), 1990

  • Dr.Med.Dent., Medizinische Fakultät, Universität Regensburg, Germany, 1992

Research & Interests

Dr. Shetty’s research interests are defined by the significant and disproportionate burden of traumatic injury and its sequelae in vulnerable populations (e.g., socioeconomically marginalized racial/ethnic minorities, uninsured, elderly) and sited at the intersection of discovery science and patient care. Through synergistic, transdisciplinary collaborations with bioengineers, computer scientists, psychologists, surgeons and systems biologists, he develops innovative, technology-based strategies to facilitate timely recognition and personalized interventions for trauma-related psychopathology. His research program has been funded continuously since 1993 through multiple NIH grants and recognized by several awards including the OMSF 2011 Research Recognition Award for Outstanding Contributions. Dr. Shetty has published over 125 research articles, books chapters and books and serves as an editorial consultant and scientific reviewer for numerous specialty journals and research organizations.

Broadly, Dr. Shetty’s research program organizes along three broad themes:

1. Collaborative care of patients with traumatic facial injury.

The multifaceted physical, social, and psychological problems affecting many survivors of facial trauma provide a compelling argument for extending trauma care beyond surgical restitution of the physical injury to addressing antecedent risk behaviors and psychosocial sequelae. Recognizing that the trauma center is often the only contact with the health care system for vulnerable populations with facial injury, most of whom are young and otherwise healthy, Dr. Shetty’s research focuses on utilizing the hospital encounter for opportunistic screening of substance use behaviors and emerging psychosocial sequelae along with targeted interventions and referrals for comprehensive management. Major themes of his trauma research include the methodical documentation of short and long-term mental health outcomes among injury survivors, development of facial injury severity scoring systems, comparative effectiveness of fracture management strategies, and developing/testing culturally-competent motivational interventions addressing antecedent substance use behaviors.

  •  Shetty V, Marshall GN (eds).  Collaborative care of the facial injury patient. Perioperative Nursing Clinics. WB Saunders Company. Vol 6 #4 Dec 2011.
  • Shetty V, Murphy D, Zigler C, Yamashita D, Belin T. Randomized Controlled Trial of Personalized Motivational Interventions in Substance-Using Patients with Facial Injuries. J. Oral Maxillofac. Surg. Volume 69, Issue 9, Sept 2011:2396-2411.
  • Shetty V, Atchison KA, Leathers R, Black E, Zigler C, Belin T. Do the benefits of rigid internal fixation of mandible fractures justify the added costs? Results from a randomized controlled trial. J. Oral Maxillofac. Surg. 2008 Nov; 66(11):2203-12.
  • Glynn S, Shetty V, Elliot-Brown K, Leathers R, Belin T, Wang J. Chronic posttraumatic stress disorder after facial injury: a 1-year prospective cohort study. The Journal of Trauma. 2007; 62(2):410-8.
2. Mobile Health technologies (mHealth) for traumatic stress and psychopathology.

The application of technology to alleviate trauma-related psychopathology is a natural extension of Dr. Shetty’s research focus on traumatic stressors. The dispositional characteristics of vulnerable communities (e.g., poverty, race) render them particular vulnerable to psychopathology (PTSD, depression, substance use disorders) following a traumatic injury. Ironically, those most in need of psychological aftercare and support are often the least likely to receive the care they need in the weeks and months following the injury. Working with technologists, Dr. Shetty develops point-of-care, decision support biosensors that utilize the differential expression of stress biomarkers in saliva to manifest maladaptive stress reactions to traumatic stressors. The development of intelligent, miniaturized biosensors capable of wireless communication will fundamentally change the way in which mental health issues in trauma patients are monitored and treated. The goal is to develop mHealth technologies that will allow front-line trauma care providers to recognize emerging maladaptive stress reactions and initiate timely referrals and interventions. Furthermore, the patient centric technologies would also act as patient enablers, allowing vulnerable individuals to overcome access barriers and facilitate quality, cost-effective and comprehensive health care that addresses existing health inequities.

  • 2013 NIH mHealth Training Institute @UCLA
  • Shetty V, Zigler C, Robles TF, Elashoff D, Yamaguchi M. Developmental validation of a point-of-care, salivary [alpha]-amylase biosensor. Psychoneuroendocrinology. 2011;36(2):193-199.
  • Yamaguchi M, Matsuda Y, Sasaki S, Sasaki M, Kadoma Y, Imai Y, Niwa D, Shetty V. Immunosensor with Fluid Control Mechanism for Salivary Cortisol Analysis. Biosens Bioelectron. 2013 March 15, 41:186-9.
  • Shetty V, Yamaguchi M. Salivary biosensors for screening trauma-related psychopathology. Oral Maxillofac Surg Clin North Am. 2010 May;22(2):269-78. In: Oral and Maxillofacial Clinics of North America. V. Shetty & G. Marshall (eds). WB Saunders Company. Vol 22 #2 May 2010
3. Oral and Dental consequences of substance use.

Substance abuse and addiction have considerable negative health consequences for the abusers' mental and physical health. Beyond the personal and societal ramifications, substance abuse can also be a major vector for the transmission of infectious diseases, particularly HIV/AIDS, and also for the infliction of violence. One of the striking health consequences of substance use in general and methamphetamine (MA) use in particular, is accelerated oral and dental disease. Dr. Shetty’s research team is spearheading the first systematic effort to characterize the burden and distribution of MA-associated oral disease, verify the association between oral health consequences and levels of MA use, and explore causal pathways that could be used as windows for opportunistic behavioral interventions. The knowledge gleaned will inform and allow dental professionals to participate more meaningfully in the collaborative care of drug-using patients and leverage the, yet unutilized, dental office setting as an entry point for identifying and supporting substance users in cessation efforts.

  • Shetty V, Mooney LJ, Zigler CM, Belin TR, Murphy D, Rawson R. The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc. 2010 Mar;141(3):307-18.


  • Research Recognition Award for outstanding contributions to specialty. Oral and Maxillofacial Surgery Foundation (2011)

  • Daniel M. Laskin Award for most outstanding research article published (2009)

  • Presidential Citation. American Dental Education Association (2009)

  • Leibinger Award for Facial Injury Research. International Association for Dental Research (2002)

  • Chair/Vice-Chair of the UCLA Academic Senate (2005-2007)

  • Visiting Professor, School of Engineering, Iwate University, Japan (2013 -2016)

Additional Information

Patient Care

Dr. Shetty provides patient care in the Faculty Group Dental Practice and the Oral and Maxillofacial Surgery Clinic.